326 related articles for article (PubMed ID: 30983151)
1. Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5.
Chen ANY; Hellyer SD; Trinh PNH; Leach K; Gregory KJ
Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():104-115. PubMed ID: 30983151
[TBL] [Abstract][Full Text] [Related]
2. "Selective" Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu
Hellyer SD; Albold S; Wang T; Chen ANY; May LT; Leach K; Gregory KJ
Mol Pharmacol; 2018 May; 93(5):504-514. PubMed ID: 29514854
[TBL] [Abstract][Full Text] [Related]
3. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
[TBL] [Abstract][Full Text] [Related]
4. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
[TBL] [Abstract][Full Text] [Related]
5. Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism.
Sengmany K; Hellyer SD; Christopoulos A; Lapinsky DJ; Leach K; Gregory KJ
Biochem Pharmacol; 2020 Jul; 177():114011. PubMed ID: 32380090
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
[TBL] [Abstract][Full Text] [Related]
7. Clickable Photoaffinity Ligands for Metabotropic Glutamate Receptor 5 Based on Select Acetylenic Negative Allosteric Modulators.
Gregory KJ; Velagaleti R; Thal DM; Brady RM; Christopoulos A; Conn PJ; Lapinsky DJ
ACS Chem Biol; 2016 Jul; 11(7):1870-9. PubMed ID: 27115427
[TBL] [Abstract][Full Text] [Related]
8. Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias.
Arsova A; Møller TC; Hellyer SD; Vedel L; Foster SR; Hansen JL; Bräuner-Osborne H; Gregory KJ
Mol Pharmacol; 2021 May; 99(5):328-341. PubMed ID: 33602724
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
[TBL] [Abstract][Full Text] [Related]
10. SAR studies on mGlu5 receptor positive allosteric modulators (2003- 2013).
Hao J; Xiong H
Curr Top Med Chem; 2014; 14(15):1789-841. PubMed ID: 25176124
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor 5 (mGlu
Hellyer SD; Albold S; Sengmany K; Singh J; Leach K; Gregory KJ
J Neurochem; 2019 Nov; 151(3):301-315. PubMed ID: 31376155
[TBL] [Abstract][Full Text] [Related]
12. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
[TBL] [Abstract][Full Text] [Related]
13. Biased agonism and allosteric modulation of metabotropic glutamate receptor 5.
Trinh PNH; May LT; Leach K; Gregory KJ
Clin Sci (Lond); 2018 Nov; 132(21):2323-2338. PubMed ID: 30389826
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
Bennett KA; Christopher JA; Tehan BG
Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5.
Kampen S; Rodríguez D; Jørgensen M; Kruszyk-Kujawa M; Huang X; Collins M; Boyle N; Maurel D; Rudling A; Lebon G; Carlsson J
ACS Chem Biol; 2022 Oct; 17(10):2744-2752. PubMed ID: 36149353
[TBL] [Abstract][Full Text] [Related]
16. Relationship between in vivo receptor occupancy and efficacy of metabotropic glutamate receptor subtype 5 allosteric modulators with different in vitro binding profiles.
Rook JM; Tantawy MN; Ansari MS; Felts AS; Stauffer SR; Emmitte KA; Kessler RM; Niswender CM; Daniels JS; Jones CK; Lindsley CW; Conn PJ
Neuropsychopharmacology; 2015 Feb; 40(3):755-65. PubMed ID: 25241804
[TBL] [Abstract][Full Text] [Related]
17. Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay-Dependent Pharmacology.
Muraleetharan A; Wang Y; Rowe MC; Gould A; Gregory KJ; Hellyer SD
Mol Pharmacol; 2023 Jun; 103(6):325-338. PubMed ID: 36921922
[TBL] [Abstract][Full Text] [Related]
18. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism.
Bridges TM; Rook JM; Noetzel MJ; Morrison RD; Zhou Y; Gogliotti RD; Vinson PN; Xiang Z; Jones CK; Niswender CM; Lindsley CW; Stauffer SR; Conn PJ; Daniels JS
Drug Metab Dispos; 2013 Sep; 41(9):1703-14. PubMed ID: 23821185
[TBL] [Abstract][Full Text] [Related]
20. Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254).
Turlington M; Noetzel MJ; Chun A; Zhou Y; Gogliotti RD; Nguyen ED; Gregory KJ; Vinson PN; Rook JM; Gogi KK; Xiang Z; Bridges TM; Daniels JS; Jones C; Niswender CM; Meiler J; Conn PJ; Lindsley CW; Stauffer SR
J Med Chem; 2013 Oct; 56(20):7976-96. PubMed ID: 24050755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
